Doxycycline topical gel - National Resilience
Alternative Names: Doxycycline gel; Doxycycline hydrogel; Doxycycline monohydrate hydrogel; NanoDOX HydrogelLatest Information Update: 14 Jun 2022
At a glance
- Originator Nanotherapeutics
- Developer Ology Bioservices
- Class Antibacterials; Antimalarials; Antineoplastics; Skin disorder therapies; Small molecules; Tetracyclines
- Mechanism of Action Protein 30S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Atopic dermatitis; Diabetic foot ulcer; Wounds
Most Recent Events
- 14 Jun 2022 Massachusetts General Hospital and NanoSHIFT plan a phase II trial in Wounds (Topical, Gel) in June 2022 (NCT05411484)
- 15 Sep 2020 Discontinued - Phase-I for Wounds in USA (Topical)
- 15 Sep 2020 Discontinued - Phase-II for Atopic dermatitis in USA (Topical)